Don't Jump to Newer Diabetes Meds for Renal Protection Yet

You may hear about using SGLT2 inhibitors (empagliflozin, etc) or GLP-1 agonists (liraglutide, etc) for renal protection in type 2 diabetes.

We know ACE inhibitors or ARBs slow progression of nephropathy in diabetes patients with hypertension and albuminuria.

Now growing data suggest certain SGLT2 inhibitors or GLP-1 agonists may also offer renal protection...independent of blood glucose lowering.